首页> 美国卫生研究院文献>other >Gene-level Integrated Metric of negative Selection (GIMS) Prioritizes Candidate Genes for Nephrotic Syndrome
【2h】

Gene-level Integrated Metric of negative Selection (GIMS) Prioritizes Candidate Genes for Nephrotic Syndrome

机译:基因水平的阴性选择综合指标(GIMS)优先考虑肾病综合征的候选基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nephrotic syndrome (NS) gene discovery efforts are now occurring in small kindreds and cohorts of sporadic cases. Power to identify causal variants in these groups beyond a statistical significance threshold is challenging due to small sample size and/or lack of family information. There is a need to develop novel methods to identify NS-associated variants. One way to determine putative functional relevance of a gene is to measure its strength of negative selection, as variants in genes under strong negative selection are more likely to be deleterious. We created a gene-level, integrated metric of negative selection (GIMS) score for 20,079 genes by combining multiple comparative genomics and population genetics measures. To understand the utility of GIMS for NS gene discovery, we examined this score in a diverse set of NS-relevant gene sets. These included genes known to cause monogenic forms of NS in humans as well as genes expressed in the cells of the glomerulus and, particularly, the podocyte. We found strong negative selection in the following NS-relevant gene sets: (1) autosomal-dominant Mendelian focal segmental glomerulosclerosis (FSGS) genes (p= 0.03 compared to reference), (2) glomerular expressed genes (p = 4×10-23), and (3) predicted podocyte genes (p = 3×10-9). Eight genes causing autosomal dominant forms of FSGS had a stronger combined score of negative selection and podocyte enrichment as compared to all other genes (p=1 x 10-3). As a whole, recessive FSGS genes were not enriched for negative selection. Thus, we also created a transcript-level, integrated metric of negative selection (TIMS) to quantify negative selection on an isoform level. These revealed transcripts of known autosomal recessive disease-causing genes that were nonetheless under strong selection. We suggest that a filtering strategy that includes measuring negative selection on a gene or isoform level could aid in identifying NS-related genes. Our GIMS and TIMS scores are available at .
机译:肾病综合症(NS)基因发现工作现在正在零星的小家庭和同类人群中进行。由于样本量小和/或缺乏家庭信息,在统计意义上超过阈值的人群中确定因果变异的能力具有挑战性。需要开发新颖的方法来鉴定NS相关的变体。确定基因推定功能相关性的一种方法是测量其负选择的强度,因为在强负选择下的基因变异更可能有害。通过结合多种比较基因组学和群体遗传学方法,我们为20,079个基因创建了基因水平的阴性选择(GIMS)得分综合指标。为了了解GIMS在NS基因发现中的作用,我们在一系列与NS相关的基因集中检查了这一得分。这些基因包括已知会在人类中导致单基因形式NS的基因,以及在肾小球,尤其是足细胞的细胞中表达的基因。我们在以下与NS相关的基因集中发现了强烈的负选择:(1)常染色体显性孟德尔病灶性节段性肾小球硬化(FSGS)基因(与参考相比p = 0.03),(2)肾小球表达的基因(p = 4×10 < sup> -23 ),以及(3)预测足细胞基因(p = 3×10 -9 )。与其他所有基因相比,导致FSGS常染色体显性遗传形式的8个基因的阴性选择和足细胞富集综合得分更高(p = 1 x 10 -3 )。总体而言,隐性FSGS基因未富集用于阴性选择。因此,我们还创建了转录本水平的阴性选择综合指标(TIMS),以量化同工型水平上的阴性选择。这些揭示了已知的常染色体隐性遗传病基因的转录本,但这些基因仍处于强选择之下。我们建议,包括在基因或同工型水平上测量阴性选择的筛选策略可以帮助鉴定与NS相关的基因。我们的GIMS和TIMS分数可在上找到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号